BT-118

N/A

Report date: 2023/08/30 17:09:05
NME

Base Information

Drug NameBT-118
Drug Alias NameBT-118
ClassificationSmall molecules
Mechanisms of ActionTyrosine-protein kinase BTK inhibitors
TargetsTyrosine-protein kinase BTK
Therapy Area/IndicationsAutoimmune DiseasesLymphoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesScinnoHub Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesScinnoHub Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsAutoimmune DiseasesLymphoma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A